Skip to main content
Clinical Trials/NCT01867268
NCT01867268
Unknown
Phase 2

Evaluating the Effect of Acetazolamide Administration and Prone Positioning Following Lumbosacral Spinal Surgery in Preventing Cerebro Spinal Fluid Leakage and Collection and Wound Dehiscence in Children.

Tehran University of Medical Sciences1 site in 1 country144 target enrollmentStarted: October 2012Last updated:

Overview

Phase
Phase 2
Enrollment
144
Locations
1
Primary Endpoint
Cerebrospinal fluid leakage

Overview

Brief Summary

  • Purpose of study : to determine the preventive effect of acetazolamide administration, prone positioning, and the combination of both following the neurosurgical interventions in lumbosacral region for cerebrospinal fluid (CSF) leak, CSF collection and wound dehiscence.

  • Sample size: 144

  • intervention groups:

  • Group A: Acetazolamide administration for 10 days

  • Group B: prone positioning for 10 days

  • Group C: Acetazolamide administration and prone positioning for 10 days

  • Group D: no intervention

  • Period of study: Autumn 2012 to the end of winter of 2015

Detailed Description

The purpose of this study is to evaluate the effect of Acetazolamide administration and prone positioning following lumbosacral spinal surgery in preventing cerebro-spinal fluid leakage and collection and wound dehissence in children admitted to Children Medical Center of Tehran since Autumn 2012 to the end of winter of 2015.The study is run under 4 categories of intervention:

  • Group A: Acetazolamide administration for 10 days
  • Group B: prone positioning for 10 days
  • Group C: Acetazolamide administration and prone positioning for 10 days
  • Group D: no intervention All patients are randomly assigned to these groups and when the patients faced with any of these complications, the protocol changes to Acetazolamide administration and prone positioning and the patient is considered as the failure of the protocol.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
— to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Untethering surgery for primary tethered cord caused by thick filum
  • Lipomyelomeningocele
  • Split cord malformation management
  • Untethering surgery in uncomplicated Dermal sinus
  • Tumors needing intradural management in lumbosacral region
  • Having any other disease with similar management technique

Exclusion Criteria

  • Infected dermoid tumors
  • Intramedullary abscess
  • Myelomeningocele surgery and related reoperation
  • Meningocele
  • Presence of hydrocephalus

Arms & Interventions

Acetazolamide

Experimental

administration of Acetazolamide for 10 days following the surgery

Intervention: Acetazolamide (Drug)

Prone positioning

Experimental

Positioning the patient following surgery for 10 days

Intervention: prone positioning (Other)

Acetazolamide and Prone positioning

Experimental

applying both Acetazolamide and prone positioning

Intervention: Acetazolamide+ prone positioning (Other)

Outcomes

Primary Outcomes

Cerebrospinal fluid leakage

Time Frame: 1month

leakage of CSF during 1 months following surgery

wound dehiscence

Time Frame: 1 month

dehiscence of the surgical wound during the first month following surgery

Cerebrospinal fluid collection

Time Frame: 1 month

collection of the CSF beneath the skin during 1 month following the surgery

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials